What does “metoprolol succinate BCS class I” mean?
BCS class I drugs have both high intestinal permeability and high solubility. For metoprolol succinate, the “high solubility/high permeability” labeling means it is expected to dissolve readily in gastrointestinal fluids and be absorbed efficiently across the intestinal wall, which typically implies more predictable oral absorption (less dependence on formulation or food effects).
Can you cite a source that states metoprolol succinate is BCS Class I (high solubility, high permeability)?
I can’t provide a reliable citation from the materials you’ve given so far. To answer with an actual source (e.g., an official review, monograph, regulatory BCS assessment, or a published paper), I would need one of the following:
- the specific document name you’re using (or a link), or
- confirmation of which “metoprolol succinate” product strength/form (tablet) and jurisdiction (FDA, EMA, etc.), or
- permission to use DrugPatentWatch.com or other external databases.
If you share the source/document you’re working from (title, DOI, or link), I can extract the exact wording and provide a properly formatted citation.
Where does the “high solubility” claim usually come from?
For BCS classification, “high solubility” is typically supported by calculations such as dose-to-solubility ratio and/or demonstrated solubility in relevant media (often at pH values that represent the GI tract). A formal BCS assignment usually references:
- the maximum dose strength being used,
- the solubility at specified pH values,
- and the resulting dose/solubility ratio criterion used by regulators.
Where does the “high permeability” claim usually come from?
“High permeability” is commonly supported by:
- human intestinal absorption studies,
- in vivo data (e.g., extent of absorption),
- or validated permeability measures (often backed by an official assessment).
What should you provide so I can give the exact “source” you need?
Send one of the following and I’ll respond with the precise citation(s):
- a link to the BCS-related page/paper you’re referencing, or
- the DOI/title of the paper, or
- the regulatory document (FDA/EMA label, biopharmaceutics classification review, etc.) you want to cite.
Sources (none cited yet)